Institute of Pharmaco-Economics: Preliminary Conference Announcement
The Evidence for Evidence: Getting Value for Money in Economic Evaluations
of Health and Health Care
Dates: 29 & 30 April 1999
Location: Shaw Conference Center, Edmonton, Alberta, Canada
Purpose: The purpose of the conference is to share the experiences of
health and health care professionals in applying evidence in general, and
economic evaluations in particular, in decision making.
Goals: - identify the extent to which such evidence is used in health and
health care decisions - explore methods to improve the applicability of
evidence to decision
making - communicate examples of evidence being incorporated in decision
making
- provide an opportunity for networking for conference participants
Who Should Attend: - decision makers in health and other government
departments, regional health authorities, formulary groups, and the
pharmaceutical industry
- clinicians
- researchers
- employers and private health benefit insurers
- students in health related disciplines
Speakers:
Mr. Bob Diprete, Health Policy Analyst, Oregon Health Plan
Prof. Michael Drummond, Director, Centre for Health Economics, University
of York, UK
Dr. David Edbrooke, Clinical Director, ICU, Royal Hallamshire Hospital,
Sheffield, UK
Dr. Mark Fendrick, Co-director of the Consortium for Health Outcomes,
Innovation, and Cost Effectiveness Studies, University of Michigan Health
System, Ann Arbor, Michigan
Mr. Ken Fyke, Chair, Board of Directors, Canadian Blood Services, Ottawa,
Ontario
Dr. Neil Graham, Chair, Expert Committee on Drug Quality and Therapeutics,
Alberta
Mr. Ed Gudaitis, Director, Business Policy and Market Access, Hoffmann-La
Roche Ltd., Mississauga, Ontario
Dr. Robert Hayward, University of Alberta
Mr. Robert Jacob, Analyst, Ministère de la Santé et des Services sociaux,
Gouvernement du Québec
Mr. David Kelly, Deputy Minister, British Columbia Ministry of Health,
Victoria, British Columbia
Hon. Ralph Klein, Premier, Alberta Government
Dr. Rejean Landry, Director, GRIG, Laval University, St. Foy, Quebec
Dr. Mitch Levine, Department of Clinical Epidemiology and Biostatistics,
McMaster University, Hamilton, Ontario
Mr. Andrew Mitchell, Director, Pharmaceutical Evaluation Section,
Department of Health & Family Services, Commonwealth of Australia
Dr. Alex McPherson, President and CEO, Biomira Inc., Edmonton, Alberta
Dr. Andrew Walker, Greater Glasgow Health Board, Glasgow, UK
Dr. Paul Wallace, Department of Regional Quality and Resource Management,
Kaiser Permanente Northwest, Portland, Oregon
Regional Health Authority decision maker (TBA)
Private Health Benefit Insurers (TBA)
Registration Fee: $ 500.00 (Cdn), $100.00 (Cdn) for students
For further information, or to receive a copy of the conference program and
registration form, please contact Joseph Gebran at the Institute of
Pharmaco-Economics by telephone (403-448-4881), fax (403-448-0018), or
email ([log in to unmask])., #710-10665 Jasper Ave, Edmonton, Alberta T5J
0S9 Canada
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
|